We are live on ! Find out more
VVM

Versant Venture Management Portfolio holdings

AUM $141M
1-Year Est. Return 190.82%
This Fund
S&P 500
This Quarter Est. Return
+21.78%
1 Year Est. Return
+190.82%
3 Year Est. Return
+375.7%
5 Year Est. Return
+81.85%
10 Year Est. Return
+4,735.29%
AUM
$84.3M
AUM Growth
+$36.3M
Cap. Flow
+$27.3M
Cap. Flow %
32.35%
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
RPTX
Repare Therapeutics
RPTX
+$27.3M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RPTX
1
DELISTED
Repare Therapeutics
RPTX
$28M 33.22%
+2,646,657
New +$27.3M
CRSP icon
2
CRISPR Therapeutics
CRSP
$4.68B
$28M 33.2%
498,558
– –
ADVM
3
DELISTED
Adverum Biotechnologies
ADVM
$8.06M 9.56%
506,823
– –
GRTS
4
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$6.94M 8.24%
3,561,150
– –
CBAY
5
DELISTED
Cymabay Therapeutics
CBAY
$5.95M 7.06%
543,753
– –
PASG icon
6
Passage Bio
PASG
$14.7M
$4.67M 5.54%
247,988
– –
ALGS icon
7
Aligos Therapeutics
ALGS
$26.3M
$2.25M 2.67%
92,815
– –
UTRS
8
DELISTED
Minerva Surgical, Inc. Common Stock
UTRS
$429K 0.51%
83,685
– –

Similar funds

POIA
Pin Oak Investment Advisors Houston, Texas $141M AUM 20.83% 1-Year Est. Return
MAM
Maytree Asset Management Hong Kong $141M AUM 114% 1-Year Est. Return
TM
TFJ Management Somerville, Massachusetts $141M AUM 9.28% 1-Year Est. Return
IA
IF Advisors San Antonio, Texas $141M AUM
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
RB
Renasant Bank Tupelo, Mississippi $141M AUM 16.9% 1-Year Est. Return
YEPX
Yorktown Energy Partners XI New York $142M AUM 130.51% 1-Year Est. Return
CFGW
Chancellor Financial Group WB Wilkes-Barre, Pennsylvania $141M AUM 23.22% 1-Year Est. Return

Versant Venture Management's Q2 2023 Portfolio in Review

As of Q2 2023, Versant Venture Management held 8 positions worth $84.3M, up 76% from $48M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Versant Venture Management deployed $27.3M of net new capital in Q2 2023, opening 1 new position. Its largest new stake was Repare Therapeutics: 2,646,657 shares worth $28M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Versant Venture Management's largest Q2 2023 buy was Repare Therapeutics: 2,646,657 shares worth $28M.
  • Versant Venture Management's ten largest holdings make up 100% of its $84.3M portfolio in Q2 2023.
  • Versant Venture Management opened 1 new position and closed 0 in Q2 2023.
  • Versant Venture Management's portfolio value rose 76% quarter-over-quarter to $84.3M.

Based on Versant Venture Management's 13F filing for Q2 2023, filed 9 Aug 2023.